October 17, 2017 2:16 AM ET


Company Overview of Cell Technologies JSC

Company Overview

Cell Technologies JSC intends to develops and manufacture cancer drug under name Paclitaxel. The company is based in Moscow, Russian Federation.

7 Koroviy Val Str.

Apt. 155

Moscow,  119049



7 495 980 5352

Key Executives for Cell Technologies JSC

Cell Technologies JSC does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Albiotech Europe
Alkor Bio Ltd. Europe
Aquanova Rus CJSC Europe
Bioprocess Group, LLC Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Tax Management Inc United States
Bertelsmann AG Europe

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Cell Technologies JSC, please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.